Boeing (BA) Offering Possible 58.73% Return Over the Next 22 Calendar Days

Boeing's most recent trend suggests a bullish bias. One trading opportunity on Boeing is a Bull Put Spread using a strike $377.50 short put and a strike $372.50 long put offers a potential 58.73% return on risk over the next 22 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $377.50 by expiration. The full premium credit of $1.85 would be kept by the premium seller. The risk of $3.15 would be incurred if the stock dropped below the $372.50 long put strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Boeing is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Boeing is bullish.

The RSI indicator is at 68.27 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Boeing

Boeing and Air New Zealand Finalize Order for Eight 787-10 Dreamliner Jets
Wed, 25 Sep 2019 09:00:00 +0000
SEATTLE, Sept. 25, 2019 /PRNewswire/ — Boeing [NYSE:BA] and Air New Zealand today finalized an order for eight 787-10 Dreamliner airplanes valued at $2.7 billion at list prices. The airplane deal, announced in May as a commitment, includes options to increase the number of aircraft from eight up to 20, and substitution rights that allow a switch from the larger 787-10 to smaller 787-9s, or a combination of the two models for future fleet and network flexibility. As the largest member of the passenger-pleasing and super-efficient Dreamliner family, the 787-10 is 224 feet long (68 meters) and can seat up to 330 passengers in a standard two-class configuration, about 40 more than the 787-9.

Here are seven Boeing 737 Max storylines you need to know
Wed, 25 Sep 2019 05:31:00 +0000
A lot has happened in the last seven months with Boeing's best selling jet, which is still grounded around the world. Here's what we know heading as September comes to a close.

Boeing (BA) Gains As Market Dips: What You Should Know
Tue, 24 Sep 2019 21:45:09 +0000
Boeing (BA) closed at $381.65 in the latest trading session, marking a +1.23% move from the prior day.

Lockheed Stock Nears Buy Point As NASA Puts Billions More In Moon Program
Tue, 24 Sep 2019 20:08:25 +0000
NASA ordered more Orion spacecraft from Lockheed Martin late Monday as the administration pushes its Artemis program to return humans to the moon within five years.

GE Wins Boeing 787 Deal As Rival Engine Faces More Delays
Tue, 24 Sep 2019 20:06:16 +0000
General Electric bagged an order for engines to power eight Boeing 787 Dreamliner airplanes, as rival Rolls-Royce engines face more delays.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.